JP2015531392A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531392A5
JP2015531392A5 JP2015535066A JP2015535066A JP2015531392A5 JP 2015531392 A5 JP2015531392 A5 JP 2015531392A5 JP 2015535066 A JP2015535066 A JP 2015535066A JP 2015535066 A JP2015535066 A JP 2015535066A JP 2015531392 A5 JP2015531392 A5 JP 2015531392A5
Authority
JP
Japan
Prior art keywords
compound
formula
morpholin
methanone
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015535066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531392A (ja
JP5989250B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/071500 external-priority patent/WO2014060398A1/en
Publication of JP2015531392A publication Critical patent/JP2015531392A/ja
Publication of JP2015531392A5 publication Critical patent/JP2015531392A5/ja
Application granted granted Critical
Publication of JP5989250B2 publication Critical patent/JP5989250B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015535066A 2012-10-18 2013-10-15 Mglur5受容体活性のモジュレーターとしてのエチニル誘導体 Expired - Fee Related JP5989250B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12188940.6 2012-10-18
EP12188940 2012-10-18
PCT/EP2013/071500 WO2014060398A1 (en) 2012-10-18 2013-10-15 Ethynyl derivatives as modulators of mglur5 receptor activity

Publications (3)

Publication Number Publication Date
JP2015531392A JP2015531392A (ja) 2015-11-02
JP2015531392A5 true JP2015531392A5 (OSRAM) 2016-07-28
JP5989250B2 JP5989250B2 (ja) 2016-09-07

Family

ID=47049067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535066A Expired - Fee Related JP5989250B2 (ja) 2012-10-18 2013-10-15 Mglur5受容体活性のモジュレーターとしてのエチニル誘導体

Country Status (26)

Country Link
US (1) US9227959B2 (OSRAM)
EP (1) EP2909180B1 (OSRAM)
JP (1) JP5989250B2 (OSRAM)
KR (1) KR101684816B1 (OSRAM)
CN (1) CN104718192B (OSRAM)
AR (1) AR093042A1 (OSRAM)
AU (1) AU2013333988B2 (OSRAM)
BR (1) BR112015006454A8 (OSRAM)
CA (1) CA2882520A1 (OSRAM)
CL (1) CL2015000891A1 (OSRAM)
CO (1) CO7200248A2 (OSRAM)
CR (1) CR20150144A (OSRAM)
EA (1) EA025667B1 (OSRAM)
ES (1) ES2599553T3 (OSRAM)
IL (1) IL237380A (OSRAM)
MA (1) MA38012B1 (OSRAM)
MX (1) MX2015004898A (OSRAM)
MY (1) MY168937A (OSRAM)
NZ (1) NZ705144A (OSRAM)
PE (1) PE20150629A1 (OSRAM)
PH (1) PH12015500398B1 (OSRAM)
SG (1) SG11201501392TA (OSRAM)
TW (1) TWI490208B (OSRAM)
UA (1) UA114529C2 (OSRAM)
WO (1) WO2014060398A1 (OSRAM)
ZA (1) ZA201500856B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA114008C2 (xx) * 2012-10-18 2017-04-10 Похідні етинілу як модулятори активності рецептора mglur5
MX378334B (es) 2015-06-03 2025-03-10 Hoffmann La Roche Modulador alostérico negativo de un receptor de glutamato metabotrópico (nam) y el uso del mismo para tratar ansiedad, dolor, depresión, parkinson y reflujo gastroesofágico.
CN108271370B (zh) * 2015-09-25 2021-03-19 (由卫生与公众服务部部长代表的)美利坚合众国 作为p2y14受体拮抗剂的三唑衍生物
BR112020008583A2 (pt) 2017-12-08 2020-10-20 Boehringer Ingelheim International Gmbh derivados de imidazopiridina e uso dos mesmos como medicamento
JP7093469B2 (ja) 2018-10-17 2022-06-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 4-ピリジニルメチル-モルホリン誘導体および医薬としてのその使用
WO2020079040A1 (en) * 2018-10-17 2020-04-23 Boehringer Ingelheim International Gmbh 4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament
US11166958B2 (en) * 2018-10-17 2021-11-09 Boehringer Ingelheim International Gmbh 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
EP3980420B1 (en) 2019-06-04 2023-04-19 Boehringer Ingelheim International GmbH Imidazopyrazine derivatives and the use thereof as medicament
TW202112378A (zh) 2019-06-04 2021-04-01 德商百靈佳殷格翰國際股份有限公司 嘌呤衍生物及其作為藥物之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
UA80888C2 (en) * 2003-06-05 2007-11-12 Hoffmann La Roche Imidazole derivatives as glutmate receptor antagonists
CA2689282A1 (en) * 2007-06-03 2008-12-11 Vanderbilt University Benzamide mglur5 positive allosteric modulators and methods of making and using same
US8853392B2 (en) * 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
US8389536B2 (en) * 2009-10-27 2013-03-05 Hoffmann-La Roche Inc. Positive allosteric modulators (PAM)
WO2013049255A1 (en) * 2011-09-26 2013-04-04 Vanderbilt University Substitued 5-(prop-1-yn-1-yl)picolinamide analogs as allosteric modulators of mglur5 receptors

Similar Documents

Publication Publication Date Title
JP2015531392A5 (OSRAM)
TWI694982B (zh) 3-側氧基-3-(芳基胺基)丙酸酯,其製備程序,及其於製備吡咯酮的應用
JP6594487B2 (ja) 抗ウイルス化合物の合成
JP2013533291A5 (OSRAM)
JP2016512823A5 (OSRAM)
ES2613850T3 (es) Procesos de síntesis asimétrica para la preparación de compuestos de aminosulfona
JP2016512824A5 (OSRAM)
JP2013518106A5 (OSRAM)
KR20250170688A (ko) Ras 저해제의 합성
JP5575357B2 (ja) 組織因子産生抑制剤
TWI546281B (zh) 使用不對稱觸媒之雙環化合物的光學離析方法
KR20220097388A (ko) 헤테로시클릭 아미드계 화합물, 이의 약학적으로 허용 가능한 염 및 이의 제조 방법 및 용도
JP2008526910A5 (OSRAM)
CN109134432B (zh) 氘代抗抑郁药物
US20180065985A1 (en) Process for making tetracyclic heterocycle compounds
JP2013245215A (ja) 不斉環化反応による光学活性二環性化合物の製造方法
JP7607799B2 (ja) 6員芳香族ヘテロ尿素環の誘導体及びその使用
JP2016000700A (ja) 2−アミノ置換ピリジン誘導体
JP6601629B2 (ja) 軸不斉を有するピリジン誘導体又はその塩、及びそれからなる不斉触媒
JP2005255660A (ja) 多官能基を有するラクタム類とその製法
CN1946709A (zh) 锂化n-甲基咪唑在亚磺基亚胺上的非对映选择性加成
CN103664917B (zh) 一种2-取代噁唑啉或2-取代噁嗪的合成方法
CN1946711A (zh) 制备咪唑化合物的非对映选择性合成方法
KR100863463B1 (ko) 광학적으로 순수한 옥소라이보스유도체의 제조방법
JP5669534B2 (ja) 光学活性含フッ素オキセテンの製造方法